Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells

Hepato-Gastroenterology

Volumn 59, Issue 120, 2012, Pages 2367-2373

  Xu, Dong ^a,b   He, Xing Xing ^a   Chang, Ying ^a   Sun, Shu Zhen ^a   Xu, Chuan Rui ^a   Lin, Ju Sheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Department of Senile Disease   (China)

Author keywords

Hepatocellular carcinoma; Integrin beta8; MiR 93; Transforming growth factor beta type II receptor

Indexed keywords

BETA INTEGRIN; BETA8 INTEGRIN; MESSENGER RNA; MICRORNA; MICRORNA 93; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HEPG2; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL CYCLE CHECKPOINTS; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; INTEGRIN BETA CHAINS; LIVER NEOPLASMS; MICRORNAS; PRIMARY CELL CULTURE; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 84872091989     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12458     Document Type: Article

References (30)

1. Srivatanakul P, Sriplung H, Deerasamee S: Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev 2004; 5:118-125.
2. Feitelson MA, Sun B, Satiroglu Tufan NL, et al.: Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002; 21:2593-2604.
3. Farazi PA, DePinho RA: Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6:674-687.
4. Girard M, Jacquemin E, Munnich A, et al.: miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 2008; 48:648-656.
5. O'Connell RM, Rao DS, Chaudhuri AA, et al.: Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10:111-122.
6. Skaftnesmo KO, Prestegarden L, Micklem DR, et al.: MicroRNAs in tumorigenesis. Curr Pharm Biotechnol 2007; 8:320-325.
7. Calin GA, Sevignani C, Dumitru CD, et al.: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101:2999-3004.
8. Yang Y, Kai G, Pu XD, et al.: Expression profile of microRNAs in fetal lung development of Sprague-Dawley rats. Int J Mol Med 2012; 29:393-402.
9. Montanini L, Lasagna L, Barili V, et al.: MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93. Cell Oncol (Dordr) 2012; 35:29-41.
10. He XX, Chang Y, Meng FY, et al.: MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2011; 7:1-13.
11. Li Z, Yang CS, Nakashima K, Rana TM: Small RNA-mediated regulation of iPS cell generation. EMBO J 2011; 30:823-834.
12. Wrana JL, Attisano L, Wieser R, et al.: Mechanism of activation of the TGF-beta receptor. Nature 1994; 370:341-347.
13. Massague J: TGF-beta signal transduction. Annu Rev Biochem 1998; 67:753-791.
14. Feng XH, Derynck R: Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 2005; 21:659-693.
15. Massuto DA, Kneese EC, Johnson GA, et al.: Transforming growth factor beta (TGFB) signaling is activated during porcine implantation: proposed role for latency-associated peptide interactions with integrins at the conceptus-maternal interface. Reproduction 2009; 139:465-478.
16. Fang L, Deng Z, Shatseva T, et al.: MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 2010; 30:806-821.
17. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
18. Murakami Y, Yasuda T, Saigo K, et al.: Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25:2537-2545.
19. Li N, Muthusamy S, Liang R, et al.: Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1. Mech Ageing Dev 2011; 132:75-85.
20. Wang P, Fu T, Wang X, Zhu W: Primary, study of miRNA expression patterns in laryngeal carcinoma by microarray. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2010; 24:535-538.
21. Du L, Schageman JJ, Subauste MC, et al.: miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res 2009; 7:1234-1243.
22. Pineau P, Volinia S, McJunkin K, et al.: miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 2010; 107:264-269.
23. Zhou J, Zhou Y, Yin B, et al.: 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro. Oncol Rep 2010; 23:121-128.
24. Massague J, Blain SW, Lo RS: TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103:295-309.
25. Derynck R, Akhurst RJ, Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29:117-129.
26. Laiho M, Weis MB, Massague J: Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem 1990; 265:18518-18524.
27. Cui W, Fowlis DJ, Cousins FM, et al.: Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes Dev 1995; 9:945-955.
28. Leemans CR, Braakhuis BJ, Brakenhoff RH: The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11:9-22.
29. Mamiya T, Yamazaki K, Masugi Y, et al.: Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Lab Invest 2010; 90:1339-1345.
30. Arnold TD, Ferrero GM, Qiu H, et al.: Defective retinal vascular endothelial cell development as a consequence of impaired integrin alphaVbeta8-mediated activation of transforming growth factor-beta. J Neurosci 2012; 32:1197-1206.